Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study.
- 2017
English
0929-5305
*Neoplasms/co [Complications]
*Rivaroxaban/tu [Therapeutic Use]
*Venous Thromboembolism/dt [Drug Therapy]
Anticoagulants/tu [Therapeutic Use]
Cohort Studies
Female
Hemorrhage/ci [Chemically Induced]
Humans
Male
Middle Aged
Neoplasms/dt [Drug Therapy]
Prospective Studies
Recurrence
Rivaroxaban/st [Standards]
Treatment Outcome
Venous Thromboembolism/et [Etiology]
MedStar Washington Hospital Center
Hematology/Oncology
Journal Article
Validation Studies